Ivermectin for COVID-19
4th treatment shown to reduce risk in
August 2020
Lower risk for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols
combine complementary and synergistic treatments. * >10%
efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for
60+ treatments. c19ivm.org
|
|
risk of death, 27.4% lower, RR 0.73, treatment 3,269, control 18,149.
|
|
risk of death/ICU, 38.0% lower, RR 0.62, treatment 3,269, control 18,149.
|
|
risk of death, 33.4% lower, RR 0.67, treatment 3,269, control 18,149, >40yo.
|
|
risk of death, 44.0% lower, RR 0.56, treatment 3,269, control 18,149, >40yo including comorbidities.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
